commercialization

Arcutis director sells 10,000 shares via pre-planned trading arrangement as stock surges 65%. ZORYVE revenue hit $372.1M in 2025, up 123% YoY, with company achieving positive operating cash flow.

PMGC Holdings shares dropped 14.34% Monday after subsidiary NorthStrive Defense secured exclusive drone technology option agreement, though commercialization success remains uncertain.

Profusa acquires BioInsights' PanOmics platform in all-equity deal, gaining $30M equity boost and expanding into multi-billion precision diagnostics market. Stock surges 135% on strategic expansion.

Rhythm Pharmaceuticals appoints veteran life sciences executive Kim Popovits to board, replacing Ed Mathers after decade-long tenure.

POET Technologies' advanced photonic technology lacks commercial proof, with stock down 36% from highs amid minimal institutional interest and execution questions.

AirJoule eyes 2026 sales launch for water-from-air technology with 60%+ institutional ownership and 2028 profitability targets supported by GE Vernova, BASF, and Carrier Global partnerships.

X Square Robot hosts first embodied AI developer conference with $280M backing, advancing humanoid robot commercialization across education, hospitality, and elder care sectors.

Aduro Clean Technologies CEO to present at three investor conferences in April 2026, detailing progress on pilot plant operations and industrial deployment plans.

Aduro Clean Technologies CEO Ofer Vicus will present at three investor conferences in April 2026, highlighting pilot operations and First-of-a-Kind facility development progress.

Co-Diagnostics ($CODX) posted $0.6M revenue and $46.9M net loss in 2025, down from prior year, amid strategic joint ventures and pipeline advancement.

Canada announces $79.5M in AI funding—$29.2M federal, $50.3M private—supporting 20 manufacturing projects across automotive, defence, life sciences, food, and advanced materials.

Abivax CEO dismisses acquisition rumors, plans equity and debt raise after Phase 3 obefazimod data in Q2 2026. $614.42M cash runway supports strategy.

Soligenix's HyBryte study shows 48% response rate, nearly double the 25% threshold, with interim results expected this quarter.

QuantumScape advances solid-state battery tech and expands into new markets, but $435M losses and delayed commercialization keep investors cautious.

WeRide integrates robotaxi service into WeChat ecosystem, plans to expand fleet from 1,023 to 2,600 vehicles by 2026, targeting global expansion across Abu Dhabi, Dubai, Singapore, and Zurich.

WeRide integrates autonomous taxis into Tencent's WeChat mobility service, launching in Guangzhou with plans for nationwide expansion and 2,000 vehicle deployment by 2026.

Three industrial stocks offer distinct growth opportunities in March 2026: Archer Aviation (eVTOL liquidity), SSR Mining ($1.5B divestiture), USA Rare Earth (rare-earth project ownership).

Kepler Fusion Technologies targets 1GW power capacity by 2028 using aneutronic fusion, pricing at 6.25¢/kWh with projected 80%+ EBITDA margins in Texas markets.

D-Wave's triple-digit revenue growth and defense bookings mask stock collapse—next earnings must prove profitability path exists.

Aduro Clean Technologies will present commercialization plans and pilot operations at the 38th Annual ROTH Conference in March 2026, featuring CEO discussions with institutional investors.